Vizient evaluates orthopedic innovations and their impact on utilization and strategies for conserving intravenous (IV) fluids in the latest Medical Device Tech Watch. In addition, this issue reviews emerging trends in cardiovascular and peripheral interventions. Read the latest Medical Device Tech Watch.

“As healthcare organizations navigate rising costs and ongoing financial pressures, it’s critical to evaluate emerging technologies and their impact on resource utilization and long-term sustainability,” said Bonnie Lai, Vizient senior vice president and general manager of clinical and physician preference. “Our team, comprised of category and clinical experts, helps providers make data-driven decisions that enhance patient care while maximizing the value of every dollar spent in healthcare.”

Featured articles include:

Recent orthopedic innovations leading to changes in utilization—Emerging technologies in orthopedic care are transforming how care is delivered and expanding treatment options. For example, spinal implants tailored to individual patients through bone density matching will expand eligibility to patients who were previously denied surgery because of low bone density. Dual-energy x-ray absorptiometry bone density scans for spine patients are expected to grow 18% to 82,000 through 2034. Advancements in robotics, implants, injury medicine and outpatient rehabilitation continue to accelerate, prompting healthcare organizations to consider where to implement changes.

IV fluid conservation strategy using a surgical wound irrigation system—The need to conserve IV fluids stems from a variety of factors, such as variable supply chains, rising costs and the ongoing goal to maintain clinical quality. Transitioning away from traditional IV fluids for surgical wound irrigation may help reduce or eliminate the potential for disposing partially used bags. A dedicated surgical wound irrigation system could also support sterilization efforts and contribute to more efficient resource use. Organizations may benefit from exploring the clinical, operational and financial implications of this approach as a potential conservation strategy.

Emerging trends and technologies in cardiovascular and peripheral interventions—The field of cardiovascular and peripheral interventions is experiencing significant changes. As these technologies mature, real-world clinical data and regulatory advancements will determine their ultimate impact. Physicians, hospitals and industry stakeholders must stay attuned to these innovations to drive better patient outcomes and operational efficiencies. This article offers key trends and the outlook for peripheral- and coronary drug-coated balloons as well as pulsed field ablation.

Read more about Medical Device Tech Watch.

About Vizient, Inc.

Vizient, Inc., the nation's largest provider-driven healthcare performance improvement company, serves more than 65% of the nation's acute care providers, including 97% of the nation's academic medical centers, and more than 35% of the non-acute market. The Vizient contract portfolio represents $140 billion in annual purchasing volume enabling the delivery of cost-effective, high-value care. With its acquisition of Kaufman Hall in 2024, Vizient expanded its advisory services to help providers achieve financial, strategic, clinical and operational excellence. Headquartered in Irving, Texas, Vizient has offices throughout the United States. Learn more at www.vizientinc.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250424694857/en/